Fluorodeoxyuridine causes bilomas after hepatic cryotherapy

Journal of Surgical Oncology

Volumn 69, Issue 1, 1998, Pages 45-50

  Soon, Patsy S ^a   Glenn, Derek ^a   Jorgensen, John ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

5 fluorodeoxyuridine (FUDR); 5 fluorouracil (5 FU); Biloma; Hepatic cryotherapy; Intra arterial chemotherapy

Indexed keywords

FLOXURIDINE;

ARTICLE; BILOMA; CELL DESTRUCTION; CHOLANGIOGRAPHY; CLINICAL ARTICLE; CRYOTHERAPY; CYTOTOXICITY; HUMAN; LIVER DISEASE; LIVER TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS;

ANTIMETABOLITES, ANTINEOPLASTIC; BILE; CRYOTHERAPY; FLOXURIDINE; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER DISEASES; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0031707120     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199809)69:1<45::AID-JSO9>3.0.CO;2-K     Document Type: Article

References (16)

1. McCall JL, Jorgensen JO, Morris DL: Hepatic artery chemotherapy for colorectal liver metastases. Aust NZ J Surg 1995;65: 338-339.
2. Rougier P, Laplanche A, Huguier M, et al.: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomised trial. J Clin Oncol 1992;10:1112-1118.
3. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, et al.: Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-1260.
4. Wagman LD, Kemeny MM, Leong L, et al.: A prospective randomised evaluation of the treatment of colorectal cancer metastases to the liver. J Clin Oncol 1990;8:1885-1893.
5. Curley SA, Roh MS, Chase JL, Hohn DC: Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 1993;166:746-748.
6. Morris DL, Ross WB, Iqbal J, et al.: Cryoablation of hepatic malignancy: An evaluation of tumour marker data and survival in 110 patients. GI Cancer 1996;4: 247-251.
7. Weaver ML, Atkinson D, Zemel R: Hepatic cryosurgery in treating colorectal metastases. Cancer 1995;76:210-214.
8. Morris DL, Horton MD, Dilley AV, et al.: The treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993;34:1156-1157.
9. Preketes AP, Caplehorn JRM, King J, et al.: Hepatic artery chemotherapy increases survival in patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg 1995;19:768-771.
10. Hohn DC, Stagg RJ, Friedman MA, et al.: A randomised trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastases to the liver: The Northern Californian Oncology Group Trial. J Clin Oncol 1989;7:1646-1654.
11. Kemeny N, Daly J, Oderman P, et al.: Hepatic artery pump infusion: Toxicity and results in patients with metastic colorectal carcinoma. J Clin Oncol 1984;2:595-600.
12. Riley DK, Babinchak TJ, Zemel R, et al: Infectious complications of hepatic cryosurgery. Clin. Infect. Dis. 1997;241001-1003.
13. Ross WB, Morris DL, Clingan PR:. Major upper GI haemorrhage associated with hepatic arterial chemoperfusion. Aust NZ J Surg 1996;66:814-817.
14. Seifert JK, Junginger T, Morris DL: A collective review of the world literature on hepatic cryolherapy. J R Coll Surg Edinb 1998;43:141-154.
15. Dilley AV, Dy DY, Warlters A, et al.: Laboratory and animal model evaluation of the Cryotech LCS 2000 in hepatic cryotherapy. Cryobiology 1993;30:74-85.
16. King J, Glenn D, Morris DL: Computed tomography changes following cryotherapy for hepatic cancer. Aust Radiol 1997;41: 22-27.